Log in
E-mail
Password
Remember
Forgot password ?
Become a member for free
Sign up
Sign up
Settings
Settings
Dynamic quotes 
OFFON

4-Traders Homepage  >  Equities  >  Nasdaq  >  MannKind Corporation    MNKD

SummaryQuotesChartsNewsAnalysisCalendarCompanyFinancialsConsensusRevisions 
News SummaryMost relevantAll newsSector newsTweets 

MannKind Corporation : MNKD, MU, ALXN and GMCR added to NASDAQ Active Stock Watch List at EPR

share with twitter share with LinkedIn share with facebook
share via e-mail
0
07/16/2013 | 03:05pm CET

New York, NY - (ACCESSWIRE) - 07/16/2013 - Equity Profile Report initiates its NASDAQ Active Stock Watch List adding MannKind Corp. (NASDAQ:MNKD), Micron Technology Inc. (NASDAQ:MU), Alexion Pharmaceuticals, Inc. (NASDAQ:ALXN) and Green Mountain Coffee Roasters, Inc. (NASDAQ:GMCR),

MannKind Corp. (NASDAQ:MNKD) a biopharmaceutical company that focuses on the discovery, development, and commercialization of therapeutic products for diabetes and cancer in the United States closed up in its previous session (+6.47%) on 7,469,136 shares traded. MannKind Corp. (NASDAQ:MNKD) is currently up (+310.99%) from its recent 52-week low which has prompted Equity Profile Report to add the stock to their NASDAQ Active Stock Watch List and Investor Poll.

To find out what other Investors are saying about MannKind Corp. (NASDAQ:MNKD)

Click Here: http://www.equityprofilereport.com/Survey.aspx?stock=MNKD&SubId=AW

Micron Technology Inc. (NASDAQ:MU) a company that together with its subsidiaries, engages in manufacturing and marketing semiconductor devices worldwide closed up in its previous session (+2.99%) on 29,731,748 shares traded after Micron Technology Inc reported its Financials. Micron Technology Inc. (NASDAQ:MU) is currently up (+155.62%) from its recent 52-week low which has prompted Equity Profile Report to add the stock to their NASDAQ Active Stock Watch List and Investor Poll.

To find out what other Investors are saying about Micron Technology Inc. (NASDAQ:MU)

Click Here: http://www.equityprofilereport.com/Survey.aspx?stock=MU&SubId=AW

Also mentioned in Equity Profile Report?s NASDAQ Active Stock Watch List and Investor Poll was: Alexion Pharmaceuticals, Inc. (NASDAQ:ALXN), Green Mountain Coffee Roasters, Inc. (NASDAQ:GMCR), Groupon, Inc. (NASDAQ:GRPN) and Zynga, Inc. (NASDAQ:ZNGA)

To see what other investors are saying about: ALXN, GMCR, GRPN, ZNGA

Click here: http://www.equityprofilereport.com/PR.aspx?stock=ALXN-GMCR-GRPN-ZNGA&SubId=AW

Equityprofilereport.com monitors and scans the markets for stock related signals as well as any external factors that might bring trading opportunities. Through a vast network of IR professionals Equityprofilereport.com is often aware of several large investor awareness campaigns being deployed. Timing is important when trading Small Caps and Penny Stocks.

Simply sign up for free and start receiving exclusive alerts.

Subscribe Here: http://www.Equityprofilereport.com

Disclosure: Equityprofilereport.com is not a registered investment advisor and nothing contained in any materials should be construed as a recommendation to buy or sell securities. Investors should always conduct their own due diligence with any potential investment. Please visit Equityprofilereport.com website, for complete risks and disclosures.

Contact Info:

Equity Profile Report

editor@Equityprofilereport.com


© Accesswire 2013
share with twitter share with LinkedIn share with facebook
share via e-mail
0
Latest news on MANNKIND CORPORATION
01/12 MANNKIND CORP : Entry into a Material Definitive Agreement, Financial Statements..
01/11 MANNKIND CORPORATION (NASDAQ : MNKD) Files An 8-K Other Events
01/10 MANNKIND CORP : Other Events (form 8-K)
01/09 MannKind Receives $30.6 Million From Sanofi
01/07 MANNKIND : Foreign-Trade Zones Board Issues Notice of Proposed Production Activi..
01/06 MANNKIND : Foreign-Trade Zone (FTZ) 76--Danbury, Connecticut Notification of Pro..
01/05 CORRECTING AND REPLACING -- MannKind Corporation to Present at the J.P. Morga..
01/05 MannKind Corporation to Present at the J.P. Morgan 2017 Healthcare Conference
01/05 MANNKIND : Announces Key Addition to Its Executive Management Ranks
01/04 MannKind Announces Key Addition to Its Executive Management Ranks
More news
Sector news : Bio Therapeutic Drugs
01/13DJNOVARTIS : Supreme Court to Weigh How Soon Firms Can Sell Copycat Biotech Drugs
01/12 Investors in big pharma, biotech look to ride out Trump storm
01/12DJHot Stocks to Watch in the U.S. and Canada
01/10 Regeneron CEO says Amgen not putting patients first in patent dispute
01/09DJCELGENE : Anticipates Slowing Sales Growth for Main Drug Revlimid
More sector news : Bio Therapeutic Drugs
News from SeekingAlpha
01/13 MannKind (MNKD) Presents At 35th Annual J.P. Morgan Healthcare Conference
01/12 MANNKIND SELLS BUILDING, EXTENDS CAS : The Good And The Bad
01/12 MannKind's (MNKD) CEO Matt Pfeffer Presents at JPMorgan Healthcare Conference..
01/12 MannKind sells Valencia real estate for $17.3M
01/09 MannKind receives final $30.6M from Sanofi under insulin put option
Advertisement
Financials ($)
Sales 2016 168 M
EBIT 2016 68,2 M
Net income 2016 55,5 M
Debt 2016 149 M
Yield 2016 -
P/E ratio 2016 5,71
P/E ratio 2017
Capi. / Sales 2016 2,84x
Capi. / Sales 2017 14,3x
Capitalization 328 M
More Financials
Chart MANNKIND CORPORATION
Duration : Period :
MannKind Corporation Technical Analysis Chart | MNKD | US56400P2011 | 4-Traders
Full-screen chart
Technical analysis trends MANNKIND CORPORATION
Short TermMid-TermLong Term
TrendsNeutralNeutralBearish
Technical analysis
Income Statement Evolution
More Financials
Consensus
Sell
Buy
Mean consensus UNDERPERFORM
Number of Analysts 3
Average target price 0,15 $
Spread / Average Target -78%
Consensus details
EPS Revisions
More Estimates Revisions
Managers
NameTitle
Matthew J. Pfeffer CEO, CFO, Director, VP & Head-Investor Relations
Kent Kresa Chairman
Raymond W. Urbanski Chief Medical Officer & Vice President
Joseph Kocinsky Chief Technology Officer & Vice President
Ronald J. Consiglio Independent Director
More about the company
Sector and Competitors
1st jan.Capitalization (M$)
MANNKIND CORPORATION7.63%328
AMGEN, INC.6.78%116 141
GILEAD SCIENCES, INC.2.04%96 267
CELGENE CORPORATION1.49%91 071
REGENERON PHARMACEUTIC..0.29%38 830
ACTELION LTD4.90%24 706
More Results